NTLA — Intellia Therapeutics, Inc.Today's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.
- Congress trades
- 15
- all time
- Members · 12m
- 0
- 0 buys · 0 sells · by trade date
- Latest filing
- 09-05
- 2023-09-05
- Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
- 1
- 13F holders
- —
- issuer resolved · no holder rows
Congress · disclosure timeline
By trade date · 24 months · 0 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.No dated NTLA rows fall inside the trailing 24 months by trade date.
Members active in NTLA
12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).No member disclosed NTLA in the trailing 12 months.
| Filed | Member | Side · Owner | Traded · Lag | Amount | Range · Flags | Src |
|---|---|---|---|---|---|---|
| 2023-09-05 | Thomas R. Carper D–DE | SELL SP (spouse-owned) | Traded 08-25 +11d | $1K–$15K | ||
| 2023-06-30 | Thomas R. Carper D–DE | BUY SP (spouse-owned) | Traded 05-22 +39d | $1K–$15K | ||
| 2022-03-03 | Donald S. Beyer, Jr. D–VA-8 | SELL JT (jointly owned) | Traded 02-28 +3d | $15K–$50K | ||
| 2021-10-30 | Donald S. Beyer, Jr. D–VA-8 | SELL JT (jointly owned) | Traded 10-29 +1d | $1K–$15K | ||
| 2021-10-01 | Donald S. Beyer, Jr. D–VA-8 | SELL JT (jointly owned) | Traded 09-20 +11d | $1K–$15K | ||
| 2021-08-07 | Donald S. Beyer, Jr. D–VA-8 | SELL JT (jointly owned) | Traded 07-21 +17d | $1K–$15K | ||
| 2021-05-17 | Thomas R. Carper D–DE | BUY SP (spouse-owned) | Traded 2020-11-20 LATE·178d | $1K–$15K | amendment pending | |
| 2021-01-31 | Donald S. Beyer, Jr. D–VA-8 | SELL JT (jointly owned) | Traded 01-15 +16d | $1K–$15K | ||
| 2020-12-01 | Donald S. Beyer, Jr. D–VA-8 | BUY JT (jointly owned) | Traded 11-18 +13d | $1K–$15K | ||
| 2020-09-06 | Donald S. Beyer, Jr. D–VA-8 | SELL JT (jointly owned) | Traded 08-26 +11d | $1K–$15K |
Institutional holders · 13F
Mapped, but not in the published aggregate.
NTLA resolves to Intellia Therapeutics, Inc. (CIK 1652130), but this build's aggregate holds no entity-keyed top-holder rows for it. NTLA on SEC EDGAR ↗
Crowding — not available in this build. The ticker resolves to Intellia Therapeutics, Inc. (CIK 1652130), but this build's aggregate holds no entity-keyed holder rows for it — its 13F securities are provisional identities without a CUSIP→issuer bridge — so it cannot be ranked among tracked names.
Congress ↔ notable managers · NTLA
Congress · last 90 days
- Buyers
- 0 — —
- Sellers
- 0 — —
filed 2026-07-31 → 2026-10-29 · statutory ranges
Notable managers
Not available for NTLA: the reviewed 13F name-and-class mapping does not name this ticker yet, so no notable manager's holding of it can be read. how tickers are mapped ↗
No moves on either side in the window.